RauCon Signs Second Partnership Agreement for Chinese Pharma Market

02 July 2021 | Friday | News


After the recent signing of a partnership agreement for the mutual promotion of services with Lingmed Ltd., a company serving the Chinese healthcare market with intelligence databases,
Image Source : Public Domain

Image Source : Public Domain

According to the agreements, RauCon will promote both companies’ service offers while Ling med and GBI will promote RauCon’s Marketplaces for Pharma Business Opportunities (www. raucon.com) among their Chinese customers. The Marketplaces euroPLX and asiaPLX are the  modern version of a platform established in 1995 for the exchange of licensing and business  opportunities, with 76 partnering events held for pharmaceutical clients from 86 countries.  

Stefan Hilscher, one of RauCon’s Managing Directors, says „We are very much looking forward  to these partnerships and expect them to support our Marketplace projects in Asia, especially  asiaPLX 1 Singapore which has been delayed by the pandemic.“ 

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close